Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives

    April 2025 in “ Experimental Dermatology ”
    Marco Spadafora, Serena Morsia, Vito Di Lernia, Shaniko Kaleci, Giovanni Pellacani, Caterina Longo
    Ruxolitinib 1.5% cream, a topical JAK1 and JAK2 inhibitor, has been approved for treating vitiligo and atopic dermatitis but is also used off-label for other skin conditions. A systematic review of 28 studies from 2012 to 2024 found that while topical ruxolitinib is effective and safe for lichenoid and granulomatous dermatoses, its efficacy in treating alopecia areata remains controversial. Despite promising results from oral formulations, consistent data for topical use in alopecia areata is lacking. The review suggests that topical ruxolitinib could be a promising treatment for certain inflammatory skin conditions, warranting further research.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    4 / 4 results

      community Ruxolitinib - Start of a case study

      in Research/Science  10 upvotes 1 year ago
      The conversation is about a user trying a new hair loss treatment, Ruxolitinib, alongside their existing regimen of finasteride, minoxidil, ketoconazole shampoo, and microneedling. They plan to apply Ruxolitinib to their temples daily for 1-2 months.

      community No hair, don't care! [24/F] :)

       60 upvotes 10 years ago
      A woman with alopecia universalis shares her positive experience of being bald, finding it freeing and less worrisome. She also discusses her skincare routine using Korean products.

      community I had claude create a protocol only using fda approved drugs.

      in Research/Science  2 upvotes 2 months ago
      A new hair loss protocol using FDA-approved topical treatments targets eight pathways, potentially improving results by 60-75% compared to the standard 40-50% from oral minoxidil and finasteride. The protocol includes minoxidil, finasteride, tacrolimus, cetirizine, bimatoprost, lithium gluconate, losartan, melatonin, NAC, caffeine, and tretinoin, with a monthly cost of $35-50 in Mexico and $80-150 in the US.

      community What else is good. Besides the big 3.

      in Chat  35 upvotes 1 year ago
      Key treatments for hair preservation include minoxidil, finasteride/dutasteride, and microneedling, with additional options like specific shampoos, oils, biotin, zinc, tretinoin, clascoterone, and low-level laser therapy. Maintaining a healthy lifestyle, reducing stress, and addressing nutrient deficiencies can also support hair health.

    Related Research

    2 / 2 results